Clinical Trial Update: Stereotactic Radiotherapy for Wet AMD (STAR) [Phase 3]

View source ↗

Summary

Phase 3 trial STAR evaluating stereotactic radiotherapy for neovascular (wet) age-related macular degeneration has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Snippet

Sponsor: King's College Hospital NHS Trust | Conditions: Neovascular (Wet) Age-related Macular Degeneration (AMD) | Phase 3 | Status: COMPLETED